Intervention: HAIC Combined Regimen Treatment Group
Found 15 matching trials
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma
PHASE1
This study is designed to evaluate the efficacy and safety of sintilimab-be...
Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer
PHASE2
The study explores the efficacy and safety of oxaliplatin combined with iri...
Status
Completed
Location
Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma
PHASE2
This study used (cTACE or DEB-TACE + FOLFOX scheme HAIC) combined with PD-1...
EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial
PHASE1
The goal of this clinical trial is to evaluate the efficacy and safety of c...
Status
Not Yet Recruiting
Location
Zhongda Hospital Affiliated to Southeast University, Department of Interventional and Vascular Surgery